MetaCap

Structure Therapeutics Insider Trades

NASDAQ: GPCRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

25.54-0.13 (-0.51%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Structure Therapeutics insider activity

Over the last 12 months, Structure Therapeutics insiders reported 26 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Coll Crespo Blas (CHIEF MEDICAL OFFICER) reporting a transaction in 12,024 shares on Sep 21, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put GPCR's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

GPCR insider transactions

Structure Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Sep 21, 2026Coll Crespo BlasCHIEF MEDICAL OFFICERConversion12,024—Form 4
Sep 18, 2026Coll Crespo BlasCHIEF MEDICAL OFFICERTax withholding10,626$124.01KForm 4
Sep 1, 2026Lin XichenCHIEF SCIENTIFIC OFFICERConversion17,817—Form 4
Sep 1, 2026Lin XichenCHIEF SCIENTIFIC OFFICEROption exercise17,817$6.06KForm 4
Aug 18, 2026Lin XichenCHIEF SCIENTIFIC OFFICERConversion11,817—Form 4
Aug 18, 2026Lin XichenCHIEF SCIENTIFIC OFFICEROption exercise11,817$4.02KForm 4
Aug 6, 2026Berrios John JosephChief Commercial OfficerAward140,766—Form 4
Aug 4, 2026Lin XichenCHIEF SCIENTIFIC OFFICERConversion11,817—Form 4
Aug 4, 2026Lin XichenCHIEF SCIENTIFIC OFFICEROption exercise11,817$4.02KForm 4
Jul 14, 2026Lin XichenCHIEF SCIENTIFIC OFFICERConversion23,634—Form 4
Jul 14, 2026Lin XichenCHIEF SCIENTIFIC OFFICEROption exercise23,634$8.04KForm 4
Jun 25, 2026Lin XichenCHIEF SCIENTIFIC OFFICERConversion23,634—Form 4
Jun 25, 2026Lin XichenCHIEF SCIENTIFIC OFFICEROption exercise23,634$8.04KForm 4
Apr 15, 2026Lang MatthewCOO & GCAward184,614—Form 4
Mar 19, 2026Stevens Raymond CCHIEF EXECUTIVE OFFICERAward260,217—Form 4
Mar 19, 2026Yoon JunCHIEF FINANCIAL OFFICERAward104,085—Form 4
Mar 19, 2026Lin XichenCHIEF SCIENTIFIC OFFICERAward43,368—Form 4
Mar 19, 2026Ma YingliCHIEF TECHNOLOGY OFFICERAward32,526—Form 4
Mar 19, 2026Coll Crespo BlasCHIEF MEDICAL OFFICERAward75,897—Form 4
Mar 19, 2026Hall AshleyChief Development OfficerAward47,706—Form 4
Mar 3, 2026Hall AshleyChief Development OfficerTax withholding4,836$101.51KForm 4
Mar 3, 2026Lin XichenCHIEF SCIENTIFIC OFFICERTax withholding18,735$393.25KForm 4
Mar 3, 2026Ma YingliCHIEF TECHNOLOGY OFFICERTax withholding11,313$237.46KForm 4
Mar 3, 2026Stevens Raymond CCHIEF EXECUTIVE OFFICERTax withholding53,454$1.12MForm 4
Mar 3, 2026Yoon JunCHIEF FINANCIAL OFFICERTax withholding22,305$468.18KForm 4
Mar 3, 2026Coll Crespo BlasCHIEF MEDICAL OFFICERTax withholding11,826$248.23KForm 4
Sep 18, 2025Coll Crespo BlasCHIEF MEDICAL OFFICERTax withholding8,106$62.77KForm 4
Sep 18, 2025Hall AshleyChief Development OfficerTax withholding6,021$46.62KForm 4
Jul 1, 2025Lin XichenCHIEF SCIENTIFIC OFFICERAward57,078—Form 4
Jul 1, 2025Ma YingliCHIEF TECHNOLOGY OFFICERAward24,459—Form 4
Jul 1, 2025Coll Crespo BlasCHIEF MEDICAL OFFICERTax withholding1,434$9.80KForm 4
Jul 1, 2025Coll Crespo BlasCHIEF MEDICAL OFFICERAward7,992—Form 4
Jul 1, 2025Stevens Raymond CCHIEF EXECUTIVE OFFICERTax withholding16,050$109.73KForm 4
Jul 1, 2025Stevens Raymond CCHIEF EXECUTIVE OFFICERAward89,697—Form 4
Jul 1, 2025Yoon JunCHIEF FINANCIAL OFFICERTax withholding7,089$48.46KForm 4
Jul 1, 2025Yoon JunCHIEF FINANCIAL OFFICERAward39,606—Form 4
Jul 1, 2025Lin XichenCHIEF SCIENTIFIC OFFICERTax withholding12,846$87.82KForm 4
Jul 1, 2025Ma YingliCHIEF TECHNOLOGY OFFICERTax withholding4,470$30.56KForm 4
Mar 1, 2025Lin XichenCHIEF SCIENTIFIC OFFICERTax withholding6,441$50.99KForm 4
Mar 1, 2025Ma YingliCHIEF TECHNOLOGY OFFICERTax withholding1,824$14.44KForm 4
Mar 1, 2025Coll Crespo BlasCHIEF MEDICAL OFFICERTax withholding1,233$9.76KForm 4
Mar 1, 2025Stevens Raymond CCHIEF EXECUTIVE OFFICERTax withholding12,495$98.92KForm 4
Mar 1, 2025Yoon JunCHIEF FINANCIAL OFFICERTax withholding5,940$47.02KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related